These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8028291)

  • 21. [Prostate cancer: between early diagnosis and total care].
    Kaulen H
    Dtsch Med Wochenschr; 2005 Oct; Suppl 1():74. PubMed ID: 16379249
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prostatic carcinoma--diagnosis, hormone therapy, radio- and chemotherapy].
    Ebert T; Bendhack ML
    Urologe A; 1997 Nov; 36(6):570-7. PubMed ID: 9487598
    [No Abstract]   [Full Text] [Related]  

  • 23. [Study of alpha1-antichymotrypsin (ACT) in prostatic carcinoma].
    Karseladze AI; Rytin IE; Matveev VB
    Arkh Patol; 2005; 67(1):30-3. PubMed ID: 15822791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Staging of prostatic carcinoma: is the classification into A, B, C, D (I, II, III, IV) still valid?
    Schroeder FH
    Prog Clin Biol Res; 1987; 243B():259-65. PubMed ID: 3659023
    [No Abstract]   [Full Text] [Related]  

  • 25. MRI earns praise in prostate screening of high-risk patients.
    Krotz D
    Diagn Imaging (San Franc); 1999 Jan; Suppl():IR21-3. PubMed ID: 11692359
    [No Abstract]   [Full Text] [Related]  

  • 26. Prostate carcinoma presentation, diagnosis, and staging: an update form the National Cancer Data Base.
    Miller DC; Hafez KS; Stewart A; Montie JE; Wei JT
    Cancer; 2003 Sep; 98(6):1169-78. PubMed ID: 12973840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prostatic cancer and pelvic node involvement: a unambiguous disease?].
    Davin JL; Culine S; Soulié M; Ravery V; Zerbib M
    Prog Urol; 2006 Apr; 16(2 Suppl 1):239-56. PubMed ID: 16724684
    [No Abstract]   [Full Text] [Related]  

  • 28. Are current staging systems for cancer serving us well?
    Scardino PT
    Nat Clin Pract Urol; 2007 Oct; 4(10):517. PubMed ID: 17921968
    [No Abstract]   [Full Text] [Related]  

  • 29. [AgNORs in prostatic and thyroid cancer cells].
    Yatani R; Ioshii SO; Shiraishi T; Yabana T; Nakano H
    Rinsho Byori; 1993 Jun; Suppl 94():138-46. PubMed ID: 8361004
    [No Abstract]   [Full Text] [Related]  

  • 30. [Prostate carcinoma. Immediate surgery in every case? (interview by Waltraut Paukstadt)].
    Harzmann R
    MMW Fortschr Med; 2002 Oct; 144(42):10. PubMed ID: 12533989
    [No Abstract]   [Full Text] [Related]  

  • 31. Baseline staging of newly diagnosed prostate cancer: a summary of the literature.
    Prando A
    Int Braz J Urol; 2004; 30(4):341-2. PubMed ID: 15679977
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of prostatic cancer (Drug Administration, Sweden)].
    Lakartidningen; 1993 May; 90(18):1766, 1769-73. PubMed ID: 8492635
    [No Abstract]   [Full Text] [Related]  

  • 33. [Endorectal magnetic resonance imaging for staging of prostatic cancer].
    Hayashi N; Kawamura J; Sugimura Y
    Hinyokika Kiyo; 1996 Oct; 42(10):767-73. PubMed ID: 8951473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate specific antigen in the diagnosis and staging of prostate cancer.
    Jung P; Wolff JM; Mattelaer P; Jakse G
    Acta Urol Belg; 1996 Sep; 64(3):1-6. PubMed ID: 8946774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The PSA: one test with three uses.
    Harv Mens Health Watch; 2001 Jul; 5(12):1-4. PubMed ID: 11511459
    [No Abstract]   [Full Text] [Related]  

  • 36. Multiparametric magnetic resonance imaging of the prostate: current status in prostate cancer detection, localization, and staging.
    Macura KJ
    Semin Roentgenol; 2008 Oct; 43(4):303-13. PubMed ID: 18774034
    [No Abstract]   [Full Text] [Related]  

  • 37. Update on prostate cancer.
    Waples MJ
    WMJ; 1999; 98(4):40-2. PubMed ID: 10555476
    [No Abstract]   [Full Text] [Related]  

  • 38. Advancements in magnetic resonance imaging of the prostate.
    Macura KJ
    Top Magn Reson Imaging; 2008 Dec; 19(6):259-60. PubMed ID: 19512847
    [No Abstract]   [Full Text] [Related]  

  • 39. Treating prostate cancer, Part II: determining its severity.
    Harv Mens Health Watch; 2008 Jun; 12(11):1-4. PubMed ID: 18807624
    [No Abstract]   [Full Text] [Related]  

  • 40. Testing intervals for PSA test.
    Douglas M; Strelnick A
    J Fam Pract; 1997 Aug; 45(2):101. PubMed ID: 9267362
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.